SpringWorks Therapeutics Inc To Discuss The DeFi Trial Data Call Transcript
Good morning and welcome to the SpringWorks Therapeutics conference call to discuss the Phase 3 DeFi topline -- sorry, Phase 3 DeFi trial topline results. At this time, I would like to turn the call over to Kim Diamond, Vice President of Communications and Investor Relations.
Thank you, Kevin, and welcome to the SpringWorks Therapeutics conference call to discuss the topline data from our Phase 3 DeFi trial evaluating nirogacestat in adult patients with progressing desmoid tumors. Leading the call today will be SpringWorks' CEO, Saqib Islam. Saqib is joined by our Chief Development Officer, Dr. Mary Smith; and our Chief Operating Officer, Dr. Badreddin Edris.
Following our prepared remarks, we will be taking questions. Slides to accompany this conference call are posted in the Investors and Media section of our website at www.springworkstx.com and an audio webcast with the corresponding slides is also available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |